中文名 | BAY-X 1005 |
英文名 | (2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid |
别名 | 化合物 T13295 |
英文别名 | DG 031 BAY 1005 Velifapon VELIFLAPON BAY-X 1005 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid (αR)-α-Cyclopentyl-4-(2-quinolinylmethoxy)-benzeneacetic acid (2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid |
CAS | 128253-31-6 |
化学式 | C23H23NO3 |
分子量 | 361.43 |
密度 | 1.242±0.06 g/cm3(Predicted) |
熔点 | 169-171 °C |
沸点 | 555.4±40.0 °C(Predicted) |
溶解度 | DMSO: 可溶解5mg/mL (澄清溶液) |
酸度系数 | 4.47±0.10(Predicted) |
存储条件 | 2-8°C |
外观 | 粉末 |
颜色 | white to beige |
体外研究 | Veliflapon (BAY X 1005; DG-031) effectively inhibits the synthesis of LTB4 in A23187-stimulated leukocytes from rats, mice and humans (IC 50 s of 0.026, 0.039 and 0.22 μM, respectively) as well as the formation of LTC4 (IC 50 of 0.021 μM) in mouse peritoneal macrophages stimulated with opsonized zymosan. |
危险品标志 | Xn - 有害物品 |
风险术语 | 22 - 吞食有害。 |
WGK Germany | 3 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!